TG Therapeutics, Inc. (TGTX)
32.00
+1.40
(+4.58%)
USD |
NASDAQ |
Dec 11, 16:00
32.05
+0.05
(+0.16%)
After-Hours: 04:38
TG Therapeutics Research and Development Expense (Quarterly): 40.88M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Karyopharm Therapeutics, Inc. | 30.42M |
| Axsome Therapeutics, Inc. | 40.04M |
| Krystal Biotech, Inc. | 13.18M |
| Arcutis Biotherapeutics, Inc. | 19.60M |